<?xml version="1.0" ?>
<document id="28691927">
  <sentence id="28691927.s0" text="Our study identifies WDR4 as an oncoprotein that negatively regulates response to hypoxia via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation">
    <entity charOffset="70-89" id="28691927.s0.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="196-201" id="28691927.s0.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="28691927.s0.e0" e2="28691927.s0.e1" id="28691927.s0.p0" relation="true"/>
  </sentence>
  <sentence id="28691927.s1" text="In xenograft and genetically engineered mouse models, the WDR4/response to hypoxia axis elevates intratumoral Tregs and M2-like macrophages and reduces CD8+ T cells to promote lung tumor growth.">
    <entity charOffset="63-82" id="28691927.s1.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="102-107" id="28691927.s1.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
  </sentence>
  <sentence id="28691927.s2" text="The WDR4/PML axis induces a set of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (uPAR), and serum amyloid A2 (acute-phase response), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.">
    <entity charOffset="161-181" id="28691927.s2.e0" ontology_id="GO_0006953" text="acute-phase response" type="GO"/>
    <entity charOffset="281-287" id="28691927.s2.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="28691927.s2.e0" e2="28691927.s2.e1" id="28691927.s2.p0" relation="true"/>
  </sentence>
</document>
